Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Sofia I PresnukhinaInstitute of Chemistry, Saint Petersburg State University, Universitetskaya Nab., 7/9, 199034 Saint Petersburg, Russia.ORCID 0000-0003-2080-0657
Valentina D KotlyarovaPharmaceutical Technology Transfer Centre, Yaroslavl State Pedagogical University Named after K.D. Ushinsky, Respublikanskaya St., 108, 150000 Yaroslavl, Russia.ORCID 0000-0001-5404-2829
Anton A ShetnevLaboratory of Engineering Profile "Physical and Chemical Methods of Analysis", Korkyt Ata Kyzylorda University, 29 Aiteke Bi Str., Kyzylorda 120014, Kazakhstan.ORCID 0000-0002-4389-461X
Sergey V BaykovInstitute of Chemistry, Saint Petersburg State University, Universitetskaya Nab., 7/9, 199034 Saint Petersburg, Russia.ORCID 0000-0002-8912-5816
Rakhymzhan TurmanovLaboratory of Engineering Profile "Physical and Chemical Methods of Analysis", Korkyt Ata Kyzylorda University, 29 Aiteke Bi Str., Kyzylorda 120014, Kazakhstan.ORCID 0000-0002-7268-1699
Nurbol AppazovLaboratory of Engineering Profile "Physical and Chemical Methods of Analysis", Korkyt Ata Kyzylorda University, 29 Aiteke Bi Str., Kyzylorda 120014, Kazakhstan.
Rakhmetulla ZhapparbergenovLaboratory of Engineering Profile "Physical and Chemical Methods of Analysis", Korkyt Ata Kyzylorda University, 29 Aiteke Bi Str., Kyzylorda 120014, Kazakhstan.
Leilya ZhussupovaLaboratory of Engineering Profile "Physical and Chemical Methods of Analysis", Korkyt Ata Kyzylorda University, 29 Aiteke Bi Str., Kyzylorda 120014, Kazakhstan.
Nurila TogyzbayevaLaboratory of Engineering Profile "Physical and Chemical Methods of Analysis", Korkyt Ata Kyzylorda University, 29 Aiteke Bi Str., Kyzylorda 120014, Kazakhstan.
Stephanus J CloetePharmaceutical Chemistry and Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom 2520, South Africa.ORCID 0000-0002-3770-8403
Mikhail K KorsakovPharmaceutical Technology Transfer Centre, Yaroslavl State Pedagogical University Named after K.D. Ushinsky, Respublikanskaya St., 108, 150000 Yaroslavl, Russia.ORCID 0000-0003-0913-2571
Vadim P BoyarskiyInstitute of Chemistry, Saint Petersburg State University, Universitetskaya Nab., 7/9, 199034 Saint Petersburg, Russia.ORCID 0000-0002-6038-0872
Anél PetzerPharmaceutical Chemistry and Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom 2520, South Africa.
Jacobus P PetzerPharmaceutical Chemistry and Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom 2520, South Africa.ORCID 0000-0002-7114-8120
Funding
National Research Foundation of South Africa 137997Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan AP23490015
6 · The paper itself
Abstract
Monoamine oxidase (MAO) plays a key role in the pathogenesis of central nervous system disorders, and MAO inhibitors have been used in the treatment of depression and Parkinson's disease. In the search for new classes of MAO inhibitors, the present study investigated a series of 1,2,4-oxadiazin-5(6
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Synthesis of 1,2,4-Oxadiazin-5(6 · full record | OpenQuestion